本帖最后由 老马 于 2013-3-13 13:43 编辑
& s, N; F$ a. U' c4 A9 t4 J$ o
- N' |1 P! N' P健择（吉西他滨）+顺铂+阿瓦斯汀
: l6 u% q. t1 _9 f) T! v Gemzar +Cisplatin + Avastin
& h4 O# w& Y* o% l! [http://annonc.oxfordjournals.org/content/21/9/1804.full
/ ?7 _2 C6 f8 ]; COverall survival with cisplatin–gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL) 1 [% Z6 u8 P8 k% [
Patients and methods: Patients (n = 1043) received cisplatin 80 mg/m2 and gemcitabine 1250 mg/m2 for up to six cycles plus bevacizumab 7.5 mg/kg (n = 345), bevacizumab 15 mg/kg (n = 351) or placebo (n = 347) every 3 weeks until progression. Primary end point was progression-free survival (PFS); OS was a secondary end point. 0 V U$ s" M9 q0 x* m
Results: Significant PFS prolongation with bevacizumab compared with placebo was maintained with longer follow-up {hazard ratio (HR) [95% confidence interval (CI)] 0.75 (0.64–0.87), P = 0.0003 and 0.85 (0.73–1.00), P = 0.0456} for the 7.5 and 15 mg/kg groups, respectively. Median OS was >13 months in all treatment groups; nevertheless, OS was not significantly increased with bevacizumab [HR (95% CI) 0.93 (0.78–1.11), P = 0.420 and 1.03 (0.86–1.23), P = 0.761] for the 7.5 and 15 mg/kg groups, respectively, versus placebo. Most patients (62%) received multiple lines of poststudy treatment. Updated safety results are consistent with those previously reported. 5 u; v" ~) l, p
Cisplatin Gemzar Avastin.PDF
(329.84 KB, 下载次数: 898)
/ M) y& X7 \7 ] P0 z* {
华为网盘附件：
6 [0 t, E/ ?4 Z. W' P( i8 a【华为网盘】ava.JPG4 M! d9 U4 C3 B/ L, ?
|
老公刚刚54岁，确诊肺癌，手术中发现
各位朋友好。
度过了慌乱的一个月，有机会发现了这个论坛，如获至宝，说说我家
妈妈肺腺9年，现在迷茫请大神路过给
病情大体介绍，患者女现69周岁，有吸烟史50年，2003年感冒憋气，CT显示肺部有片炎症，
男77周岁 肺腺癌 2018年右上肺切除
父亲77岁 2018肺腺癌右上肺切除，今年6月份增强CT检查报告（右上肺术后，术区见金属缝
碎碎念治疗期间的营养支持
多少年前，那会并不了解什么是肠内营养剂，只知道要做营养支持，如何做好营养支持，是
肿瘤患者放化疗后如何补充营养，专家
整理者：pear审核人：王闫飞教授放化疗在对抗肿瘤的过程中起着至关重要的作用，但同时
显身卡
